The appropriate injection site, syringe, concentration, storage method and administration schedule depend on the prescribed product and individual treatment plan
Csorba A, Maka E, Maneschg OA, Szabo A, Szentmary N, Csidey M, Resch M, Imre L, Knezy K, Nagy ZZ (2020) Examination of corneal deposits in nephropathic cystinosis using in vivo confocal microscopy and anterior segment optical coherence tomography: an age-dependent cross sectional study
Neurocrit Care
Zhu Z, Guo Y, Shi H, Liu CL, Panganiban RA, Chung W, OConnor LJ, Himes BE, Gazal S, Hasegawa K, Camargo CA Jr, Qi L, Moffatt MF, Hu FB, Lu Q, Cookson WOC, Liang L
The decision between these peptides and established regenerative medicine approaches should be based on available evidence, regulatory status, and individual patient factors
To the Author or anyone else that has a reference for this statement?: The exception to this rule is the single preparation of the sub-Q or IM dose that exceeds the volume safely injected at a single site